Skip to content

A Rehabilitation Tool to Determine Patient's Stay in Hospital After Joint Replacement

A Rehabilitation Tool to Determine Patient's Stay in Hospital After Joint Replacement

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03777007
Enrollment
55
Registered
2018-12-17
Start date
2019-08-26
Completion date
2022-04-19
Last updated
2023-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Joint Replacement Surgery

Brief summary

SPARTA force plate is used as rehabilitation tool in this study. The device is Force Plate coupled with SPARTA scan software that enables quick assessment of individual movement and balance within minutes. The magnitude as well as efficiency of force production is analyzed to determine an patient recovery graph.

Detailed description

The investigator hope to learn co-relation between the rehab tool and clinical findings and analyse association if any. In this study, force plate is rehab tool, which will optimize care according to the patient's specific needs and provided insights to patients length of stay in the hospital. these data driven insights will be used to observe correlation between machine and clinic data

Interventions

DEVICESPARTA force plate

The Sparta Platform includes force plate hardware coupled with Sparta Scan software that enables quick assessment of an individual's movement and balance within minutes

Sponsors

Derek Amanatullah
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Patient scheduled for Primary unilateral total joint replacement * Patient age should be more than or equal to 18 years. * Patient must speak English

Exclusion criteria

* Patients undergoing bilateral primary knee replacement surgery * Patients undergoing revision knee replacement surgery * No uncorrectable deformity * No deformity greater than 15 degree * No hip arthritis * No wheelchair dependency Patients not willing and capable to sign the written informed consent

Design outcomes

Primary

MeasureTime frameDescription
Length of Stay in Hospital Through DischargeUp to 8 daysLength of stay will depend on the score generated by device.

Secondary

MeasureTime frameDescription
Gait Aid UsePreoperative and month 3 post-surgeryThe gait aide use ranges in the order of decreasing performance as Nothing \> Cane/Walking Sticks \> crutch \> walker.
Knee Society Score (KSS)Month 3 post-surgeryTo assess the effectiveness of the device by calculating Knee Society Score (KSS) at 3 months following surgery. The scale ranges from 0-100 with grading as: Score 80-100 - Excellent; Score 70-79 - Good; Score 60-69 - Fair; Score below 60 - Poor.
Range of MotionPreoperative and month 3 post-surgeryTo assess the effectiveness of the device by calculating range of motion (extension and flexion). Higher extension scores and lower flexion scores represent greater flexibility.

Countries

United States

Participant flow

Pre-assignment details

55 participants signed informed consent; 40 were allocated to the study arm

Participants by arm

ArmCount
Sparta Force Plate
The Sparta platform includes force plate hardware coupled with Sparta Scan software that enables assessment of an individual's movement and balance
40
Total40

Baseline characteristics

CharacteristicSparta Force Plate
Age, Continuous64.83 years
STANDARD_DEVIATION 9.34
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
28 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
9 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
Race (NIH/OMB)
Asian
1 Participants
Race (NIH/OMB)
Black or African American
1 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
9 Participants
Race (NIH/OMB)
White
28 Participants
Region of Enrollment
United States
40 Participants
Sex: Female, Male
Female
21 Participants
Sex: Female, Male
Male
19 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 40
other
Total, other adverse events
0 / 40
serious
Total, serious adverse events
0 / 40

Outcome results

Primary

Length of Stay in Hospital Through Discharge

Length of stay will depend on the score generated by device.

Time frame: Up to 8 days

Population: Participants with available data are included in the analysis.

ArmMeasureValue (MEDIAN)
Sparta Force PlateLength of Stay in Hospital Through Discharge3 days
Secondary

Gait Aid Use

The gait aide use ranges in the order of decreasing performance as Nothing \> Cane/Walking Sticks \> crutch \> walker.

Time frame: Preoperative and month 3 post-surgery

Population: Participants with available data at each time point are included in the analysis.

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
Sparta Force PlateGait Aid UsePreoperativeNone37 Participants
Sparta Force PlateGait Aid UsePreoperativeCane/Walking Sticks3 Participants
Sparta Force PlateGait Aid UseMonth 3None38 Participants
Sparta Force PlateGait Aid UseMonth 3Cane/Walking Sticks0 Participants
Secondary

Knee Society Score (KSS)

To assess the effectiveness of the device by calculating Knee Society Score (KSS) at 3 months following surgery. The scale ranges from 0-100 with grading as: Score 80-100 - Excellent; Score 70-79 - Good; Score 60-69 - Fair; Score below 60 - Poor.

Time frame: Month 3 post-surgery

ArmMeasureValue (MEAN)Dispersion
Sparta Force PlateKnee Society Score (KSS)90.4 score on a scaleStandard Deviation 11.39
Secondary

Range of Motion

To assess the effectiveness of the device by calculating range of motion (extension and flexion). Higher extension scores and lower flexion scores represent greater flexibility.

Time frame: Preoperative and month 3 post-surgery

Population: Participants with available data at each time point are included in the analysis.

ArmMeasureGroupValue (MEAN)Dispersion
Sparta Force PlateRange of MotionExtension - month 30.3 degreesStandard Deviation 1.15
Sparta Force PlateRange of MotionFlexion - preoperative113.9 degreesStandard Deviation 11.78
Sparta Force PlateRange of MotionFlexion - month 3116.0 degreesStandard Deviation 8.54
Sparta Force PlateRange of MotionExtension - preoperative2.4 degreesStandard Deviation 3.34

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026